Companies: 10,795·Total market cap: $144.5T
Prothena Corporation plc

Prothena Corporation plc

PRTANASDAQHealthcare● Active
$8.56
$-0.23(-2.62%)
Market Cap$448143709
P/E Ratio
52W High$11.8
52W Low$4.95

Prothena Corporation plc (PRTA) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

prta · stock forecast · 28 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 28 Wall Street analysts in the past 3 months

SellBuy

Buy

28 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
20
Hold
6
Sell
2
Strong Sell
0
Total: 28 · Buy rate: 71.4%

12-Month Price Target

High

$19.00

Consensus

$19.00

+122.0% upside

Low

$19.00

Median: $19 · Last Close: $8.56

The Prothena Corporation plc (PRTA) analyst consensus is Buy, based on ratings from 28 Wall Street analysts over the past 3 months. The average 12-month PRTA price target is $19.00, representing +122.0% upside from the current price of $8.56.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Analyst price target coverage is insufficient to generate a forecast chart for this stock.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$8.224.00%

1-day model range: $8.16–$8.28. Peak: $8.28 (-4.00%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$4-50.0%
2028$3-63.8%
2029$3-69.2%
2030$2-71.8%
2031-73.1%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

0%7%93%
0Buy
1Neutral
13Sell
RSI (14)37.4Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · PRTA · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$8.94SELL
MA 10$9.46SELL
MA 20$9.51SELL
MA 50$10.13SELL
MA 100$9.65SELL
MA 200$9.64SELL
Current $PRTA · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$8.96SELL
EMA 10$9.24SELL
EMA 20$9.55SELL
EMA 50$9.80SELL
EMA 100$9.75SELL
EMA 200$9.93SELL
Current $PRTA · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Citizens2026-05-08
Maintains
Market OutperformMarket Outperform
RBC Capital2026-02-20
Maintains
Sector PerformSector Perform
Citizens2025-12-01
Maintains
Market OutperformMarket Outperform
HC Wainwright & Co.2025-11-07
Maintains
BuyBuy
RBC Capital2025-11-07
Maintains
Sector PerformSector Perform
Piper Sandler2025-10-28
Maintains
OverweightOverweight
HC Wainwright & Co.2025-10-07
Maintains
BuyBuy
JMP Securities2025-09-02
Maintains
Market OutperformMarket Outperform
Piper Sandler2025-08-28
Maintains
OverweightOverweight
Chardan Capital2025-08-28
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Prothena Corporation plc (PRTA) stock. Of the recent 142 rating actions, 6 were upgrades and 12 were downgrades. 28 analysts currently cover PRTA.

Analyst Recommendation Trends

Buy ratings11
Hold ratings00
Sell ratings00

PRTA analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$83M

↓ 38.2% YoY

Revenue Next Year

$26M

↓ 68.3% YoY

EPS This Year

$0.05

EPS Next Year

$-1.03

↓ 2307.1% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast PRTA EPS of $0.05 for the current fiscal year, based on estimates from 4 analysts. The PRTA revenue forecast is $83M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The PRTA stock forecast is supported by two independent data sources: analyst consensus ratings from 28 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus PRTA price target is $19.00 (+122.0% upside), with an analyst consensus of Buy.

The PRTA short-term stock prediction for tomorrow is $8.22 (-4.00%). The PRTA stock price prediction for 2027 estimates an average of $4. The PRTA stock prediction for 2030 projects a range of $2–$3.

Prothena Corporation plc trades on NASDAQ under the ticker PRTA. The PRTA stock outlook for 2027 is broadly positive, supported by a Buy consensus among 71% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

PRTA forecast · 8 questions

According to 28 Wall Street analysts, the average 12-month PRTA price target is $19.00, with a high forecast of $19.00 and a low of $19.00. The median price target is shown in the chart above when available. This implies +122.0% potential upside from the current price of $8.56.

PRTA price targetWhat is PRTA price targetPRTA analyst price targetPRTA 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.